14 Μάι A Randomised, Double Blind, Placebo Controlled Trial with Vitamin D3 as an Add on Treatment to Interferon β-1b in Patients With Multiple Sclerosis
Abstract Objectives To study the safety and efficacy of vitamin D3 as an add on therapy to interferon β-1b (IFNB) in patients with multiple sclerosis (MS). Methods 1 year, double blind, placebo controlled, randomised study in 66 MS patients. The primary outcomes were...